Cite
Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease.
MLA
Pinto-Lopes, Pedro, et al. “Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease.” Clinical and Translational Gastroenterology, vol. 12, no. 3, Mar. 2021, p. e00320. EBSCOhost, https://doi.org/10.14309/ctg.0000000000000320.
APA
Pinto-Lopes, P., Melo, F., Afonso, J., Pinto-Lopes, R., Rocha, C., Melo, D., Macedo, G., Dias, C. C., Carneiro, F., & Magro, F. (2021). Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease. Clinical and Translational Gastroenterology, 12(3), e00320. https://doi.org/10.14309/ctg.0000000000000320
Chicago
Pinto-Lopes, Pedro, Francisco Melo, Joana Afonso, Rui Pinto-Lopes, Cátia Rocha, Daniel Melo, Guilherme Macedo, Cláudia Camila Dias, Fátima Carneiro, and Fernando Magro. 2021. “Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease.” Clinical and Translational Gastroenterology 12 (3): e00320. doi:10.14309/ctg.0000000000000320.